•Executive Summary o Market Overview •Market Landscape o Market ecosystem o Value chain analysis •Market Sizing o Market definition o Market segment analysis o Market size 2019 o Market outlook: Forecast for 2019 - 2024 •Five Forces Analysis o Bargaining power of buyers o Bargaining power of suppliers o Threat of new entrants o Threat of substitutes o Threat of rivalry o Market condition •Market Segmentation by Product o Market segments o Comparison by Product placement o Broad-spectrum antibiotics - Market size and forecast 2019-2024 o Narrow-spectrum antibiotics - Market size and forecast 2019-2024 o Market opportunity by Product •Market Segmentation by Application o Market segments o Comparison by Application placement o Antibiotics for human use - Market size and forecast 2019-2024 o Antibiotics for veterinary use - Market size and forecast 2019-2024 o Market opportunity by Application •Market Segmentation by Other 1 o Market segments o Comparison by Other1 placement o Natural - Market size and forecast 2019-2024 o Semisynthetic - Market size and forecast 2019-2024 o Synthetic - Market size and forecast 2019-2024 o Market opportunity by Other1 •Market Segmentation by Other 2 o Market segments o Comparison by Other2 placement o Bacteriostatic - Market size and forecast 2019-2024 o Bactericidal - Market size and forecast 2019-2024 o Market opportunity by Other2 •Customer landscape o Overview •Geographic Landscape o Geographic segmentation o Geographic comparison o APAC - Market size and forecast 2019-2024 o North America - Market size and forecast 2019-2024 o Europe - Market size and forecast 2019-2024 o South America - Market size and forecast 2019-2024 o MEA - Market size and forecast 2019-2024 o Key leading countries o Market opportunity by geography •Drivers, Challenges, and Trends o Market drivers o Volume driver - Demand led growth o Volume driver - Supply led growth o Volume driver - External factors o Volume driver - Demand shift in adjacent markets o Price driver - Inflation o Price driver - Shift from lower to higher-priced units o Market challenges o Market trends •Vendor Landscape o Overview o Landscape disruption o Vendor Analysis •Vendors covered o Market positioning of vendors o Abbott Laboratories o AbbVie Inc. o AstraZeneca Plc o Bayer AG o F. Hoffmann-La Roche Ltd. o Johnson & Johnson o Mayne Pharma Group Ltd. o Merck KGaA o Pfizer Inc. o Sanofi •Appendix o Scope of the report o Currency conversion rates for US$ o Research methodology o List of abbreviations •1.Key Finding 1 •2.Key Finding 2 •3.Key Finding 3 •4.Key Finding 5 •5.Key Finding 6 •6.Key Finding 7 •7.Key Finding 8 •8.Key Finding 9 •9.Key Finding 10 •10.Key Finding 11 •11.Market in focus •13.Parent market •16.Market characteristics •18.Offerings of vendors included in the market definition •20.Market segments. •25.Global - Market size and forecast 2019 - 2024 ($ billion) •26.Global market: Year-over-year growth 2019 - 2024 (%) •27.Five forces analysis 2019 & 2024 •29.Bargaining power of buyers •30.Bargaining power of suppliers •31.Threat of new entrants •32.Threat of substitutes •33.Threat of rivalry •35.Market condition - Five forces 2019 •36.Product placement - Market share 2019-2024 (%) •37.Comparison by Product placement •38.Broad-spectrum antibiotics - Market size and forecast 2019-2024 ($ billion) •39.Broad-spectrum antibiotics - Year-over-year growth 2019-2024 (%) •40.Narrow-spectrum antibiotics - Market size and forecast 2019-2024 ($ billion) •41.Narrow-spectrum antibiotics - Year-over-year growth 2019-2024 (%) •42. Market opportunity by Product •43.Application placement - Market share 2019-2024 (%) •44.Comparison by Application placement •45.Antibiotics for human use - Market size and forecast 2019-2024 ($ billion) •46.Antibiotics for human use - Year-over-year growth 2019-2024 (%) •47.Antibiotics for veterinary use - Market size and forecast 2019-2024 ($ billion) •48.Antibiotics for veterinary use - Year-over-year growth 2019-2024 (%) •49. Market opportunity by Application •50.Other1 placement - Market share 2019-2024 (%) •51.Comparison by Other1 placement •52.Natural - Market size and forecast 2019-2024 ($ billion) •53.Natural - Year-over-year growth 2019-2024 (%) •54.Semisynthetic - Market size and forecast 2019-2024 ($ billion) •55.Semisynthetic - Year-over-year growth 2019-2024 (%) •56.Synthetic - Market size and forecast 2019-2024 ($ billion) •57.Synthetic - Year-over-year growth 2019-2024 (%) •58. Market opportunity by Other1 •59.Other2 placement - Market share 2019-2024 (%) •60.Comparison by Other2 placement •61.Bacteriostatic - Market size and forecast 2019-2024 ($ billion) •62.Bacteriostatic - Year-over-year growth 2019-2024 (%) •63.Bactericidal - Market size and forecast 2019-2024 ($ billion) •64.Bactericidal - Year-over-year growth 2019-2024 (%) •65. Market opportunity by Other2 •66.Customer landscape •67.Market share by geography 2019-2024 (%) •68.Geographic comparison •70.APAC - Market size and forecast 2019-2024 ($ billion) •71.APAC - Year-over-year growth 2019-2024 (%) •73.North America - Market size and forecast 2019-2024 ($ billion) •74.North America - Year-over-year growth 2019-2024 (%) •76.Europe - Market size and forecast 2019-2024 ($ billion) •77.Europe - Year-over-year growth 2019-2024 (%) •79.South America - Market size and forecast 2019-2024 ($ billion) •80.South America - Year-over-year growth 2019-2024 (%) •82.MEA - Market size and forecast 2019-2024 ($ billion) •83.MEA - Year-over-year growth 2019-2024 (%) •85.Key leading countries •86.Market opportunity by geography ($ billion) •87.Impact of drivers and challenges •88.Vendor landscape •90.Landscape disruption •92.Industry risks •94.Vendors covered •96.Market positioning of vendors •98.Abbott Laboratories - Overview •99.Abbott Laboratories - Business segments •100.Abbott Laboratories - Key offerings •101.Abbott Laboratories - Key customers •102.Abbott Laboratories - Segment focus •104.AbbVie Inc. - Overview •105.AbbVie Inc. - Business segments •106.AbbVie Inc. - Key offerings •107.AbbVie Inc. - Key customers •108.AbbVie Inc. - Segment focus •110.AstraZeneca Plc - Overview •111.AstraZeneca Plc - Business segments •112.AstraZeneca Plc - Key offerings •113.AstraZeneca Plc - Key customers •114.AstraZeneca Plc - Segment focus •116.Bayer AG - Overview •117.Bayer AG - Business segments •118.Bayer AG - Key offerings •119.Bayer AG - Key customers •120.Bayer AG - Segment focus •122.F. Hoffmann-La Roche Ltd. - Overview •123.F. Hoffmann-La Roche Ltd. - Business segments •124.F. Hoffmann-La Roche Ltd. - Key offerings •125.F. Hoffmann-La Roche Ltd. - Key customers •126.F. Hoffmann-La Roche Ltd. - Segment focus •128.Johnson & Johnson - Overview •129.Johnson & Johnson - Business segments •130.Johnson & Johnson - Key offerings •131.Johnson & Johnson - Key customers •132.Johnson & Johnson - Segment focus •134.Mayne Pharma Group Ltd. - Overview •135.Mayne Pharma Group Ltd. - Business segments •136.Mayne Pharma Group Ltd. - Key offerings •137.Mayne Pharma Group Ltd. - Key customers •138.Mayne Pharma Group Ltd. - Segment focus •140.Merck KGaA - Overview •141.Merck KGaA - Business segments •142.Merck KGaA - Key offerings •143.Merck KGaA - Key customers •144.Merck KGaA - Segment focus •146.Pfizer Inc. - Overview •147.Pfizer Inc. - Business segments •148.Pfizer Inc. - Key offerings •149.Pfizer Inc. - Key customers •150.Pfizer Inc. - Segment focus •152.Sanofi - Overview •153.Sanofi - Product and service •154.Sanofi - Key offerings •155.Sanofi - Key customers •156.Sanofi - Segment focus •158.Currency conversion rates for US$ •159.Research Methodology •160.Validation techniques employed for market sizing •161.Information sources •162. List of abbreviations

Abbott Laboratories, AbbVie Inc., AstraZeneca Plc, Bayer AG, F. Hoffmann-La Roche Ltd., Johnson & Johnson, Mayne Pharma Group Ltd., Merck KGaA, Pfizer Inc., Sanofi